Clinical Trials Directory

Trials / Completed

CompletedNCT06206629

Contralateral R1 in Amyotrophic Lateral Sclerosis

Evaluation of Contralateral R1 Component of the Blink Reflex in Patients With Amyotrophic Lateral Sclerosis

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting both upper and lower motor neurons. Electroneuromyography is an important tool for the diagnosis. Previous studies have shown that different components of the blink reflex, such as the latencies of homo- and contralateral R2 responses can be affected. Studies have found that a contralateral R1 component can appear in neurological diseases with affection of the central nervous system especially upper motor neuron, such as HTLV1 infection. Thus, you aim to determine if a contralateral R1 component could be present in ALS.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTblink reflex evaluationA blink reflex evaluation will be performed in all subjects

Timeline

Start date
2024-02-15
Primary completion
2024-09-05
Completion
2024-09-05
First posted
2024-01-16
Last updated
2024-10-09

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06206629. Inclusion in this directory is not an endorsement.